1-acetyl-2-picolinoylhydrazine (NSC-68626) in the treatment of advanced cancer.
D000284:Administration, Oral; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D010847:Picolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006834:Hydrazines; D010847:Picolines